Traumatic Brain Injury Clinical Trial
Official title:
Evaluation the Effects of French Maritime Pine Bark Extract Supplementation on the Inflammatory Biomarkers, Nutritional and Clinical Status in Traumatic Brain Injury Patients, in Intensive Care Unit; A Randomized Clinical Trial
Introduction: Traumatic brain injury (TBI) is one of the major health and socioeconomic
problems in the world. Immune-enhancing enteral formula has been proven to significantly
reduce infection rate in TBI patient. One of the ingredients that can be used in
immunonutrition formulas to reduce inflammation and oxidative stress is French maritime pine
bark extract.
Objective: The main objective of present study is surveying the effect of French maritime
pine bark extract on the clinical, nutritional and inflammatory status of TBI patients as the
first human study in the world.
Method: this is double-blind, randomized controlled trial. Block randomization are used.
Intervention group will receive French maritime pine bark extract supplement (OLIGOPIN) 150
mg for 10 days. Control group will receive placebo for the same duration. Inflammatory status
(IL-6, IL- 1β, C-reactive protein) and oxidative stress status (Malondialdehyde, total
antioxidant capacity), at the base line, at the 5th day and at the end of the study (10th
day) are measured. APACHE ІІ (acute physiologic and chronic health evaluation II) for
assessment of clinical status of patients and Nutric questionnaires for assessment of
nutritional status filled out at the base line, 5th day and the end of study. SOFA
(sequential organ failure assessment) questionnaire for assessment of organ failure filled
out every other day. The mortality rate will be asked by phone within 28 days of the start of
the intervention. Weight, body mass index and body composition at baseline, 5th day and 10th
day of intervention are measured. All analyses will be conducted by initially assigned study
arm in an intention-to-treat analysis. The data will be expressed as mean ± SD.
Randomization:
investigators randomly assign eligible patients on enrolment (1:1) to either the control
group or the intervention group. Randomization is stratified by site and a randomization list
of unique patient identifiers is generated by the study statistician using a
computer-generated random block size. The classification is based on age (18 to 40 and 40 to
65 years old), gender (male / female) and APACHEII score (0 to 35 and 35 to 71) using
quadruple blocks.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT05503316 -
The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System
|
N/A | |
| Completed |
NCT04356963 -
Adjunct VR Pain Management in Acute Brain Injury
|
N/A | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Terminated |
NCT03698747 -
Myelin Imaging in Concussed High School Football Players
|
||
| Recruiting |
NCT05130658 -
Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training
|
N/A | |
| Recruiting |
NCT04560946 -
Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI
|
N/A | |
| Completed |
NCT05160194 -
Gaining Real-Life Skills Over the Web
|
N/A | |
| Recruiting |
NCT02059941 -
Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines
|
N/A | |
| Recruiting |
NCT03940443 -
Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
|
||
| Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
| Completed |
NCT04465019 -
Exoskeleton Rehabilitation on TBI
|
||
| Recruiting |
NCT04530955 -
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
|
N/A | |
| Recruiting |
NCT03899532 -
Remote Ischemic Conditioning in Traumatic Brain Injury
|
N/A | |
| Suspended |
NCT04244058 -
Changes in Glutamatergic Neurotransmission of Severe TBI Patients
|
Early Phase 1 | |
| Completed |
NCT03307070 -
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
|
N/A | |
| Recruiting |
NCT04274777 -
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
|
||
| Withdrawn |
NCT04199130 -
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
|
N/A | |
| Withdrawn |
NCT05062148 -
Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery
|
N/A | |
| Withdrawn |
NCT03626727 -
Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
|
Early Phase 1 |